Can a smartphone app ease suffering for advanced cancer patients?

NCT ID NCT04989556

Ongoing Symptom relief Sponsor: M.D. Anderson Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a technology-enhanced symptom monitoring program, used alongside standard in-person and remote palliative care, can improve quality of life for 119 adults with advanced solid tumors who are also in phase I immunotherapy trials. Participants use the program to report symptoms, and researchers track changes in distress and satisfaction. The goal is to see if adding digital tools makes palliative care more effective.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: technology-enhanced symptom monitoring program
What this could lead to: If it works, this could show that adding a digital symptom tracker to standard palliative care improves quality of life for people with advanced cancer.
What could go wrong: This is a small, early-stage study with only 119 participants, so results may not apply to everyone. The intervention is supportive, not curative, so it won't change the cancer itself.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED MALIGNANT SOLID NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADVANCED MALIGNANT SOLID NEOPLASM

Contacts and locations

Locations

M D Anderson Cancer Center

Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.